Florian Berghea, Camelia Elena Berghea, Dumitru Zaharia, Andreea Iulia Trandafir, Elena Cristina Nita, Violeta Maria Vlad
For many years, inflammatory rheumatic diseases (IRDs) represented a source of disappointment in medical care caused by the mediocre efficacy of the available treatments. Some of these diseases, like Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS), caused fear in the general population, especially due to associated joint deformities and subsequent disabilities. However, in the last 20 years, a new successful class of antirheumatic drugs has become available: biologic Disease-Modifying Antirheumatic Drugs (bDMARDs)...
2021: Frontiers in Medicine